SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Taradevi Innani, Sagar Innani, Vishnukanta Innani & PACs SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Resignation of Company Secretary & Compliance Officer of the Company SHILPA MEDICARE LTD. - 530549 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Shilpa Medicare Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here SHILPA MEDICARE LTD. - 530549 - Declaration Of Postal Ballot Results
Declaration of Postal Ballot Results SHILPA MEDICARE LTD. - 530549 - Declaration Of Postal Ballot Results
Declaration of Postal Ballot Results SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Regulation'), we wish to inform you that India Ratings & Research (Ind-Ra) has affirmed Shilpa Medicare Limited's Long-Term Issuer Rating at 'IND A+''. SHILPA MEDICARE LTD. - 530549 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to the Regulation 30 of SEBI LODR, please find enclosed a copy of the Postal Ballot Notice together with the Explanatory Statement for seeking approval of the Members for the resolution set out therein.
Serum backed Mylab to make and sell Covid-19 vax, working on 2-3 platforms
Partners with Shilpa Medicare to manufacture vaccines, therapeutics SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Shilpa Medicare Limited through its wholly owned subsidiary Shilpa Biologicals Private Limited has entered in to a strategic tie-up for manufacturing arrangement with Mylab Discovery Solutions SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation